Spots Global Cancer Trial Database for palliative radiotherapy
Every month we try and update this database with for palliative radiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Palliative Lattice Stereotactic Body Radiotherapy (SBRT) | NCT04133415 | Cancer Palliative Radi... | Lattice stereot... Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Study of Avelumab-M3814 Combinations | NCT03724890 | Oncology Solid Tumors | M3814 M3814 Avelumab Radiotherapy | 18 Years - | EMD Serono | |
| Radiotherapy & Combi in Metastatic Melanoma | NCT02392871 | Metastatic Mela... | Palliative radi... Dabrafenib and ... | 18 Years - | Melanoma and Skin Cancer Trials Limited | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) | NCT01446744 | Metastatic Tumo... | Stereotactic ab... palliative radi... | 18 Years - | Lawson Health Research Institute | |
| A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. | NCT05717166 | Metastatic Tumo... | Palliative Radi... Chemotherapy Hormone therapy Immunotherapy Targeted System... Observation Stereotactic Ab... Surgery Radiofrequency ... Fractionated Ra... | 18 Years - | Lawson Health Research Institute | |
| Chemoradiotherapy in Patients With Localised Lung Cancer | NCT00193921 | Non Small Cell ... | Vinorelbine High dose Radio... Gemcitabine Cisplatin High Dose Radio... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial | NCT01341756 | Gastric Cancer | Palliative Radi... | 21 Years - | National University Hospital, Singapore | |
| Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC | NCT03051672 | Metastatic Brea... | Pembrolizumab Palliative radi... | 18 Years - | Dana-Farber Cancer Institute | |
| Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine Metastases | NCT02832830 | Vertebral Bony ... | IMRT fractionated RT | 18 Years - 85 Years | Heidelberg University | |
| CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer | NCT00862030 | Non-small Cell ... | CT- simulation ... | 18 Years - | AHS Cancer Control Alberta | |
| Descriptors and Predictors of Burden and Information Needs | NCT04069494 | Advanced Lung C... Symptoms | questionnaires | 18 Years - | Chulabhorn Cancer Center | |
| Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
| WHOle Brain Irradiation or STEreotactic Radiosurgery for Five or More Brain Metastases (WHOBI-STER) | NCT04891471 | Neurocognitive ... Quality of Life Activities of D... | Stereotactic Ra... Whole Brain Irr... | 18 Years - | Mediterranean Institute of Oncology | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) | NCT01446744 | Metastatic Tumo... | Stereotactic ab... palliative radi... | 18 Years - | Lawson Health Research Institute | |
| Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer | NCT03853733 | Rectal Cancer | rectal cancer r... | 18 Years - | Consorci Sanitari de Terrassa | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | NCT03862911 | Metastatic Tumo... | palliative radi... Stereotactic ab... | 18 Years - | British Columbia Cancer Agency | |
| Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer | NCT03853733 | Rectal Cancer | rectal cancer r... | 18 Years - | Consorci Sanitari de Terrassa | |
| Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy | NCT04249362 | Non-small Cell ... | Durvalumab | 18 Years - 130 Years | AstraZeneca | |
| Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases | NCT02832765 | Vertebral Bony ... | A B C D | 18 Years - 80 Years | Heidelberg University | |
| Hypo-Fractionated Radiotherapy in Breast Cancer | NCT03669497 | Breast Cancer Advanced Breast... Metastatic Brea... | Hypo fractionat... | 18 Years - | Tata Medical Center | |
| Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer | NCT03658434 | Hormone-refract... | Palliative radi... | 18 Years - | Zealand University Hospital | |
| A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change | NCT05010031 | Metastatic Canc... | Palliative radi... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer | NCT00400426 | Head and Neck N... Recurrence Neoplasms, Seco... | Radiotherapy | 18 Years - | University of Aarhus | |
| Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
| M3541 in Combination With Radiotherapy in Solid Tumors | NCT03225105 | Solid Tumors | M3541 Palliative Radi... | 18 Years - | EMD Serono | |
| Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial | NCT05947513 | Cervical Cancer | Curcumin Palliative radi... | 18 Years - | Addis Ababa University | |
| Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
| Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone | NCT00609934 | Renal Cell Carc... | Sorafenib external beam r... | 18 Years - | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
